Clincosm LogoSign in Get a demo

lymphoproliferative disorders

Showing 26 - 42 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

Completed
  • Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
  • +2 more
  • tabelecleucel
  • La Jolla, California
  • +26 more
Mar 24, 2021

Expression of CD19 Complex in Lymphoproliferative Disorders

Not yet recruiting
  • Lymphoproliferative Disorders
  • Flow cytometry
  • (no location specified)
Feb 2, 2021

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia Trial in Ann Arbor (Pacritinib)

Terminated
  • Lymphoma, T-Cell, Cutaneous
  • +6 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jan 20, 2021

Myelodysplastic Disorders, Leukemia, Multiple Myeloma Trial in Houston (FLUDARABINE, CAMPATH 1H, FK50)

Completed
  • Myelodysplastic Disorders
  • +4 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Epstein-Barr Virus Infections, Lymphoproliferative Disorders Trial in Houston (Intravenous injection of EBV specific CTLs)

Completed
  • Epstein-Barr Virus Infections
  • Lymphoproliferative Disorders
  • Intravenous injection of EBV specific CTLs
  • Houston, Texas
  • +1 more
Jan 15, 2020

Fluorodeoxyglucose-Positron Emission Tomography to Evaluate

Completed
  • Lymphoproliferative Disorders
  • Lymphoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 3, 2018

    Chidamide, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse Trial in Shanghai (Chidamide combined with R-GDP)

    Unknown status
    • Chidamide
    • +15 more
    • Chidamide combined with R-GDP
    • Shanghai, Shanghai, China
    • +1 more
    Dec 12, 2017

    Psoriasis, Cutaneous T Cell Lymphoma, Lymphoproliferative Disorders Trial in Graz (Photo(chemo)therapy)

    Recruiting
    • Psoriasis
    • +10 more
    • Photo(chemo)therapy
    • Graz, Styria, Austria
      Medical University of Graz, Department of Dermatology
    Nov 7, 2017

    Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Houston

    Terminated
    Has Results
    • Myelodysplastic and Myeloproliferative Disorders
    • +7 more
    • Houston, Texas
    • +1 more
    Mar 29, 2016

    Transfusion-related EBV Infection Among Allogeneic Stem Cell

    Unknown status
    • Lymphoproliferative Disorders
    • Determining the source of EBV in severe EBV infections
    • Vancouver, British Columbia, Canada
    • +2 more
    Jul 20, 2015

    Hematologic Tumors, Lymphoproliferative Disorders, Leukemia Trial in Houston (Clofarabine)

    Completed
    • Hematologic Neoplasms
    • +3 more
    • Houston, Texas
      University of Texas M. D. Anderson Cancer Center
    Mar 24, 2015

    Leukemia, Lymphoproliferative Disorders Trial (Phenethyl Isothiocyanate (PEITC))

    Withdrawn
    • Leukemia
    • Lymphoproliferative Disorders
    • Phenethyl Isothiocyanate (PEITC)
    • (no location specified)
    Apr 12, 2013

    Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoma Trial in Liverpool (Plerixafor and G-CSF)

    Unknown status
    • Multiple Myeloma
    • +3 more
    • Plerixafor and G-CSF
    • Liverpool, Merseyside, United Kingdom
      Dept of Haematology, University of Liverpool
    Aug 20, 2010

    Liver Disease, Lymphoproliferative Disorders Trial in Houston (EBV-specific autologous CTL)

    Completed
    • Liver Disease
    • Lymphoproliferative Disorders
    • EBV-specific autologous CTL
    • Houston, Texas
      Texas Children's Hospital
    Jan 12, 2010

    HIV, Immunologic Deficiency Syndromes, Lymphoproliferative Disorders Trial run by the NCI (all-trans-retinoic acid with

    Completed
    • HIV Infections
    • +2 more
    • all-trans-retinoic acid with IFN-alpha2a
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Mar 3, 2008

    Lymphoproliferative Disorders Trial run by the (MEDI-507)

    Terminated
    • Lymphoproliferative Disorders
    • Bethesda, Maryland
      National Cancer Institute/National Institutes of Health
    Jun 12, 2007

    Sarcoma, Kaposi, HIV, Lymphoproliferative Disorders Trial in New Orleans (A-007)

    Completed
    • Sarcoma, Kaposi
    • +2 more
    • New Orleans, Louisiana
      DEKK - TEC Inc
    Jun 23, 2005